Howard Federoff

Howard Federoff

Company: Kenai Therapeutics

Job title: Chief Medical Officer


Unlocking the Potential of iPSC Therapies for Parkinson’s Disease 9:00 am

Investigating the expanding application of iPSC technology to create cell-based therapies for Parkinson’s disease Highlighting the importance of developing reliable preclinical models to assess the safety and effectiveness of iPSC therapies in Parkinson’s diseaseRead more

day: Conference Day Two

Industry Leaders’ Fireside Chat: Highlights & Hurdles from the Past Year 9:00 am

An interactive panel discussion from the industry leaders of the field to set the scene on the iPSC therapy space. Ask your questions live to understand the expert’s thoughts on key topics including: Highlighting and celebrating the big wins for iPSC community like recent start-ups and progress being made by US & Asian biopharma Considering…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.